Western blot and immunohistochemistry validated MYC overexpression in non-neoplastic hepatocytes and liver tumor tissues at fetal (E17.5) and different postnatal stages (Figs. 1d, S1b), suggesting that MYC is activated in the fetal stage. Here, MYC is linked to Neoplasm of the liver.